Quantcast

Latest Retina Stories

2014-07-14 23:03:57

The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment for diabetic macular edema (DME) patients. Hicksville and Hauppauge, NY (PRWEB) July 14, 2014 The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment for...

Researcher Reveals Novel Treatment For A Form Of Childhood Blindness
2014-07-14 03:18:37

McGill University Health Centre An international research project, led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, reports that a new oral medication is showing significant progress in restoring vision to patients with Leber congenital amaurosis (LCA). Until now, this inherited retinal disease that causes visual impairment ranging from reduced vision to complete blindness, has remained untreatable. The study is published today in the scientific...

2014-07-14 12:20:58

Cedars-Sinai Medical Center Preliminary results show the device, created at Cedars-Sinai and developed by NeuroVision Imaging, may provide highly predictive early detection of changes associated with Alzheimer's disease A noninvasive optical imaging device developed at Cedars-Sinai can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease, according to preliminary results from investigators conducting a clinical trial in...

2014-07-01 12:28:07

MENLO PARK, Calif., July 1, 2014 /PRNewswire/ -- Avalanche Biotechnologies, Inc., a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the appointment of Samuel B. Barone, M.D. in the role of Chief Medical Officer. Dr. Barone will lead the company's clinical development programs, including advancing Avalanche's lead product, AVA-101 for the treatment of wet AMD. Dr. Barone will report to...

2014-06-30 04:21:34

Professor Eberhart Zrenner Discusses the Future of Artificial Vision at Premier International Ophthalmology Meeting PARIS, June 30, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, Retina Implant's co-founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of Tuebingen, Germany, presented...

2014-06-24 12:28:49

Dr. Michael Bennett Only Private Sector Surgeon Selected Nationwide HONOLULU, June 24, 2014 /PRNewswire/ -- Dr. Michael Bennett MD, FACS, founder of The Retina Institute of Hawaii, has been named one of thirteen prestigious surgeons across the United States to conduct the procedure for the Argus® II Retinal Prosthesis System. The Argus II (also called the "bionic eye") is an implantable visual prosthetic and was selected in 2013 CNN's Top 10, Time Magazine's Best Inventions and in...

2014-06-23 04:20:48

Retina Implant AG's Lead Clinical Trial Investigator Presents Patient Experiences with the Alpha IMS Subretinal Implant LONDON, June 23, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, Retina Implant's co-founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of Tuebingen, Germany,...

2014-06-21 08:20:25

Foundation Fighting Blindness Co-Founder and Chairman Gordon Gund and Family to Catalyze Retinal Degenerative Disease Research with Unlimited Donation Matching Challenge for Two Years COLUMBIA, Md., June 21, 2014 /PRNewswire/ -- In support of the fight to eradicate blindness, Foundation Fighting Blindness Chairman and Co-Founder Gordon Gund and his family announced a matching gift challenge they hope will result in millions of dollars in funds to accelerate pre-clinical,...

2014-06-17 10:58:53

University of California - San Diego Some neurons turn to neighbors to help take out the trash It's broadly assumed that cells degrade and recycle their own old or damaged organelles, but researchers at University of California, San Diego School of Medicine, The Johns Hopkins University School of Medicine and Kennedy Krieger Institute have discovered that some neurons transfer unwanted mitochondria – the tiny power plants inside cells – to supporting glial cells called astrocytes...

2014-06-06 09:41:21

NIH/National Eye Institute NIH-funded study could help improve retinal prosthetic devices In laboratory tests, researchers have used electrical stimulation of retinal cells to produce the same patterns of activity that occur when the retina sees a moving object. Although more work remains, this is a step toward restoring natural, high-fidelity vision to blind people, the researchers say. The work was funded in part by the National Institutes of Health. Just 20 years ago, bionic...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related